XT
GLMD icon

XTX Topco’s Galmed Pharmaceuticals GLMD Stock Holding History

XTX Topco’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.35K Sell
1,877
-923
-33% -$4.6K ﹤0.01% 4043
2026
Q1 		$10.8K Buy
2,800
+1,419
+103% +$7.65K ﹤0.01% 3673
2025
Q4 		$8.29K Buy
+1,381
New +$12.9K ﹤0.01% 3208

Other funds holding GLMD

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's GLMD Position: Q2 2026 in Review

XTX Topco reduced its Galmed Pharmaceuticals (GLMD) stake by 33% in Q2 2026, selling an estimated $4.6K and leaving 1,877 shares worth $8.35K. The position accounts for ﹤0.01% of the portfolio, ranked #4043.

XTX Topco first reported a position in GLMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.8K in Q1 2026. 11 funds tracked by Wall St. Rank hold GLMD as of Q2 2026.

  • XTX Topco held 1,877 shares of Galmed Pharmaceuticals worth $8.35K as of Q2 2026.
  • XTX Topco sold 923 Galmed Pharmaceuticals shares in Q2 2026, an estimated $4.6K.
  • Galmed Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4043 holding.
  • XTX Topco first reported a position in Galmed Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • XTX Topco's Galmed Pharmaceuticals position peaked at $10.8K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.